Insider Shareholders with Direct Ownership of Rvl Pharmaceuticals PLC (RVLP)
This section provides a comprehensive overview of the insiders with direct ownership of Rvl Pharmaceuticals PLC (RVLP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
RVL Pharmaceuticals plc Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Avista Healthcare Partners, L.P.
> 10% Shareholder |
8,000,000 | 0 | 23,730,864 $0 | 1 |
Aug 08, 2022
Added 25.21%
|
|
Altchem Ltd
> 10% Shareholder |
0 | 17,544,196 | 4,941,101 $0 | 3 |
Oct 20, 2023
Reduced 49.06%
|
|
Brian A Markison
Chief Executive Officer |
850,000 | 0 | 2,976,020 $0 | 1 |
Aug 08, 2022
Added 22.22%
|
|
James Schaub
EVP and COO |
243,800 | 47,373 | 524,835 $0 | 8 |
May 18, 2023
Reduced 1.05%
|
|
Christopher Klein
General Counsel & Secretary |
0 | 46,861 | 180,573 $0 | 6 |
May 18, 2023
Reduced 2.93%
|
|
Andrew J. Einhorn
Chief Financial Officer |
0 | 25,742 | 141,473 $0 | 3 |
Jan 24, 2022
Reduced 6.36%
|
|
Tina Marie De Vries
EVP, Research & Development |
0 | 31,118 | 136,141 $0 | 4 |
May 18, 2022
Reduced 3.85%
|
|
Fred G Weiss
Director |
61,188 | 29,595 | 118,466 $0 | 4 |
Aug 27, 2021
Reduced 4.44%
|
|
Alisa Lask
Director |
115,000 | 12,000 | 112,557 $0 | 3 |
Aug 10, 2023
Reduced 9.63%
|
|
Gregory L Cowan
Director |
40,000 | 29,595 | 90,055 $0 | 4 |
Jul 05, 2023
Added 30.76%
|
|
Michael J. De Biasi
Director |
40,000 | 0 | 40,000 $0 | 1 |
Jul 05, 2023
Added 50.0%
|